Exchange: NASDAQ·Updated 07:30 PM EDT
NPCE logo

NPCE NeuroPace Inc

$14.41
$0.28
(1.98%)
Today
Closed $14.41
$0.00
(0.00%)
After Hours
Reported EarningsAug 11
Mkt Cap$494.61M
Vol129,420.00

About NPCE

NeuroPace, Inc. develops, manufactures, and markets implantable devices for treating epilepsy and neurological disorders. It offers implantable components, which include the RNS neurostimulator as well as depth and cortical strip leads. The firm's RNS System is designed for the treatment of medically refractory partial epilepsy and includes implantable and external products. The company was founded by Rebecca L. Kuhn, Frank M. Fischer on November 19, 1997 and is headquartered in Mountain View, CA.
49

Neutral Sentiment

How do you feel about NPCE?

Advertisement|Remove ads.